AustraliaHealth

Healthcare technology company Beamtree (ASX:BMT) announced CFO Michelle Spiller will resign effective July 24.

Telix Pharmaceuticals (ASX:TLX) generated US$247 million in group revenue for the second quarter ended June 30.

Entropy Neurodynamics (ASX:ENP) secured a South African patent for psilocybin-based fibromyalgia treatments.

Medical device developer PainChek (ASX:PCK) has appointed Karen Holzberger as CEO, effective Aug. 17.

Neurizon Therapeutics (ASX:NUZ) has finished participant enrolment for Regimen I of the HEALEY ALS Platform Trial.

LTR Pharma (ASX:LTP) has executed a definitive telehealth distribution agreement with U.S. platform Shed Holdings.

Dimerix (ASX:DXB) secured an $10 million non-dilutive loan facility with SKIPTAN to fund its Phase 3 clinical trials.

Mayne Pharma (ASX:MYX) appointed Griffin D. Buchanan as CFO, effective Aug. 1.

Argenica Therapeutics (ASX:AGN) reports positive preclinical data as lead drug ARG-007 reduces concussion damage.

Immuron (ASX:IMC) reported global sales of $7.7 million for FY26, marking a 6% increase over the prior comparative period.

Cyclopharm (ASX:CYC) executed an agreement with University Hospitals to install its Technegas system across 11 clinical locations.

Immutep (ASX:IMM) has secured United States patent number 12,673,088 for its cancer immunotherapy combination treatments.